A randomized, double-blind, placebo-controlled, multi-center trial of the engineered human anti body to TNF (CDP571) for steroid sparing and maintenance of remission in patients with steroid-dependent Crohn's disease
- 30 April 2000
- journal article
- abstracts
- Published by Elsevier in Gastroenterology
- Vol. 118 (4) , A655
- https://doi.org/10.1016/s0016-5085(00)84761-7
Abstract
No abstract availableThis publication has 0 references indexed in Scilit: